IP Library Assignment 056389/0904
Patent Assignment
Reel/Frame 056389/0904

Assignment of Assignor's Interest

Recorded: 2021-05-28 Pages: 5
Assignors
ROBERTS, ANDREW W.
Executed: 2021-02-02
SEYMOUR, JOHN F.
Executed: 2021-02-01
Assignee
ABBVIE INC.
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, ILLINOIS, 60064
Covered Property (1)
Combination Therapy of a Type Ii Anti-CD20 Antibody with a Selective Bcl-2 Inhibitor
Application: 17/187,468 →
Publication: US 2021/0177838
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 28, 2021
From: SAMPATH, DEEPAK; FAIRBROTHER, WAYNE JOHN
To: GENENTECH, INC.
Reel/Frame 056389/0859 →
Assignment of Assignor's Interest May 28, 2021
From: ROCHE GLYCART AG
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 056389/0878 →
Assignment of Assignor's Interest May 28, 2021
From: KLEIN, CHRISTIAN
To: ROCHE GLYCART AG
Reel/Frame 056389/0882 →
Assignment of Assignor's Interest May 28, 2021
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 056389/0886 →
Assignment of Assignor's Interest May 28, 2021
From: GENENTECH, INC.
To: GENENTECH, INC.; ABBVIE INC.
Reel/Frame 056389/0896 →
Assignment of Assignor's Interest May 28, 2021
From: HUMERICKHOUSE, ROD A.
To: ABBVIE INC.
Reel/Frame 056389/0920 →